The Swiss hip replacement implants market is projected to register a substantial CAGR of 10.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2023 to 2030.
Market Segmentation
Swiss Hip Replacement Implants Market, By Product Type (Femoral Reconstruction, Acetabular Reconstruction, Hip Resurfacing, Revision Hip Implants, Bearing and Porous Metal Technologies, and Total Replacement Implants), Material (Ceramic-On-Cross-Linked Polyethylene, Ceramic-On-Polyethylene, Ceramic-On-Ceramic, Metal-On-Cross-Linked Polyethylene, and Others), End User (Orthopedic Clinics, Hospitals & Surgery Centers, and Others), Distribution Channel (Direct Sales, Third Party Distributors, and Retail Sales), Country (Switzerland) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Swiss hip replacement implants market are:
Rise in the prevalence of hip injuries due to sports
Increasing demand for minimally invasive procedures
Market Players
Some of the major market players operating in the Swiss hip replacement implants market are:
Atesos
B. Braun Melsungen AG
Conformis
Corin Group
DePuy Synthes Companies
DJO, LLC
Exactech, Inc.
KYOCERA Medical Technologies, Inc.
Mathys Ltd Bettlach
Medacta International
MicroPort Scientific Corporation
Smith & Nephew
Stryker
Symbios Orthopedie S.A.
Waldemar Link GmbH & Co. KG
Zimmer Biomet
TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF THE SWISS HIP REPLACEMENT IMPLANTS MARKET 11
1.4 LIMITATIONS 12
1.5 MARKETS COVERED 12
2 MARKET SEGMENTATION 14
2.1 MARKETS COVERED 14
2.2 GEOGRAPHICAL SCOPE 15
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 DBMR TRIPOD DATA VALIDATION MODEL 16
2.6 MULTIVARIATE MODELLING 19
2.7 PRODUCT TYPE LIFELINE CURVE 19
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.9 DBMR MARKET POSITION GRID 21
2.10 MARKET END USER COVERAGE GRID 22
2.11 VENDOR SHARE ANALYSIS 23
2.12 SECONDARY SOURCES 24
2.13 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 27
4.1 PESTEL ANALYSIS 28
4.2 PORTER'S FIVE FORCES MODEL 29
4.3 3D HIP MARKET & NAVIGATION/COMPUTERIZED SURGERY 30
5 EUROPE HIP REPLACEMENT IMPLANTS MARKET 32
5.1 OVERVIEW 32
5.2 EXECUTIVE SUMMARY 33
5.3 REGULATIONS 36
6 MARKET OVERVIEW 39
6.1 DRIVERS 41
6.1.1 A RISE IN THE PREVALENCE OF HIP ARTHRITIS 41
6.1.2 GOVERNMENT AND PRIVATE INITIATIVES FOR HEALTHCARE AND INSURANCE INVESTMENTS 42
6.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES AND CEMENTLESS IMPLANTS 43
6.1.4 REVISION OF IMPLANTS 44
6.2 RESTRAINTS 45
6.2.1 PRODUCT RECALLS AND PRODUCT FAILURES 45
6.2.2 COMPLICATIONS OF IMPLANTS 45
6.3 OPPORTUNITIES 46
6.3.1 RISING PRODUCT INNOVATIONS AND DEVELOPMENT OWING TO TECHNOLOGICAL ADVANCEMENTS 46
6.3.2 RISING ADOPTION OF CUSTOMIZED HIP PROSTHESIS 47
6.3.3 INCREASE IN ADOPTION OF NAVIGATED AND ROBOTICS IN HIP REPLACEMENT PROCEDURES 47
6.4 CHALLENGES 48
6.4.1 HIGH COSTS ASSOCIATED WITH HIP REPLACEMENTS AND IMPLANTS 48
6.4.2 STRINGENT REGULATORY FRAMEWORK 48
7 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY PRODUCT TYPE 50
7.1 OVERVIEW 51
7.2 TOTAL REPLACEMENT IMPLANTS 54
7.3 FEMORAL RECONSTRUCTION 54
7.4 ACETABULAR RECONSTRUCTION 54
7.5 HIP RESURFACING 55
7.6 REVISION HIP IMPLANTS 55
7.7 BEARING AND POROUS METAL TECHNOLOGIES 56
8 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY MATERIAL 57
8.1 OVERVIEW 58
8.2 CERAMIC-ON-METAL 61
8.3 METAL-ON-POLYETHYLENE 61
8.4 METAL-ON-METAL 61
8.5 CERAMIC-ON-POLYETHYLENE 62
8.6 CERAMIC-ON-CERAMIC 62
9 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY END USER 63
9.1 OVERVIEW 64
9.2 HOSPITALS & SURGERY CENTERS 67
9.3 ORTHOPEDIC CLINICS 67
9.4 OTHERS 68
10 SWISS HIP REPLACEMENT IMPLANTS MARKET, BY DISTRIBUTION CHANNEL 69
10.1 OVERVIEW 70
10.2 DIRECT SALES 73
10.3 RETAIL SALES 73
10.4 ONLINE PHARMACY AND E-COMMERCE 74
11 SWISS HIP REPLACEMENT IMPLANTS MARKET, COMPANY LANDSCAPE 75
11.1 COMPANY SHARE ANALYSIS: SWITZERLAND 75
12 SWOT ANALYSIS 76
13 COMPANY PROFILE 77
13.1 STRYKER 77
13.1.1 COMPANY SNAPSHOT 77
13.1.2 REVENUE ANALYSIS 77
13.1.3 PRODUCT PORTFOLIO 78
13.1.4 RECENT DEVELOPMENT 78
13.2 SMITH & NEPHEW 79
13.2.1 COMPANY SNAPSHOT 79
13.2.2 REVENUE ANALYSIS 79
13.2.3 PRODUCT PORTFOLIO 80
13.2.4 RECENT DEVELOPMENT 80
13.3 ZIMMER BIOMET 81
13.3.1 COMPANY SNAPSHOT 81
13.3.2 REVENUE ANALYSIS 81
13.3.3 PRODUCT PORTFOLIO 82
13.3.4 RECENT DEVELOPMENTS 82
13.4 MEDACTA INTERNATIONAL 83
13.4.1 COMPANY SNAPSHOT 83
13.4.2 REVENUE ANALYSIS 83
13.4.3 PRODUCT PORTFOLIO 84
13.4.4 RECENT DEVELOPMENT 84
13.5 DEPUY SYNTHES COMPANIES (A PART OF JHONSON & JHONSON MEDICAL DEVICES COMPANIES) (2022) 85
13.5.1 COMPANY SNAPSHOT 85
13.5.2 REVENUE ANALYSIS 85
13.5.3 PRODUCT PORTFOLIO 86
13.5.4 RECENT DEVELOPMENT 86
13.6 ATESOS 87
13.6.1 COMPANY SNAPSHOT 87
13.6.2 PRODUCT PORTFOLIO 87
13.6.3 RECENT DEVELOPMENT 87
13.7 B. BRAUN MELSUNGEN AG 88
13.7.1 COMPANY SNAPSHOT 88
13.7.2 REVENUE ANALYSIS 88
13.7.3 PRODUCT PORTFOLIO 89
13.7.4 RECENT DEVELOPMENT 89
13.8 CORIN GROUP 90
13.8.1 COMPANY SNAPSHOT 90
13.8.2 PRODUCT PORTFOLIO 90
13.8.3 RECENT DEVELOPMENT 90
13.9 CONFORMIS (2022) 91
13.9.1 COMPANY SNAPSHOT 91
13.9.2 REVENUE ANALYSIS 91
13.9.3 PRODUCT PORTFOLIO 92
13.9.4 RECENT DEVELOPMENT 92
13.10 D.J.O., LLC 93
13.10.1 COMPANY SNAPSHOT 93
13.10.2 PRODUCT PORTFOLIO 93
13.10.3 RECENT DEVELOPMENT 93
13.11 EXACTECH, I.N.C. 94
13.11.1 COMPANY SNAPSHOT 94
13.11.2 PRODUCT PORTFOLIO 94
13.11.3 RECENT DEVELOPMENT 95
13.12 KYOCERA MEDICAL TECHNOLOGIES, INC. (2022) 96
13.12.1 COMPANY SNAPSHOT 96
13.12.2 REVENUE ANALYSIS 96
13.12.3 PRODUCT PORTFOLIO 97
13.12.4 RECENT DEVELOPMENT 97
13.13 MICROPORT SCIENTIFIC CORPORATION (2022) 98
13.13.1 COMPANY SNAPSHOT 98
13.13.2 REVENUE ANALYSIS 98
13.13.3 PRODUCT PORTFOLIO 99
13.13.4 RECENT DEVELOPMENT 99
13.14 MATHYS LTD BETTLACH 100
13.14.1 COMPANY SNAPSHOT 100
13.14.2 PRODUCT PORTFOLIO 100
13.14.3 RECENT DEVELOPMENT 101
13.15 SYMBIOS ORTHOPEDIE S.A. 102
13.15.1 COMPANY SNAPSHOT 102
13.15.2 PRODUCT PORTFOLIO 102
13.15.3 RECENT DEVELOPMENTS 102
13.16 WALDEMAR LINK GMBH & CO. KG 103
13.16.1 COMPANY SNAPSHOT 103
13.16.2 PRODUCT PORTFOLIO 103
13.16.3 RECENT DEVELOPMENT 103
14 QUESTIONNAIRE 104
15 RELATED REPORTS 107